New Directions in the Treatment of Breast Cancer: Updates from the 29th Annual San Antonio Breast Cancer Symposium (SABCS)

Last Modified: February 1, 2007

Share article

Conference Dates: February 1, 2007
Conference Location: Seattle, WA

Conference Dates: February 5, 2007
Conference Location: Pittsburgh, PA

Conference Dates: February 6, 2007
Conference Location: Cleveland, OH

Conference Dates: February 7, 2007
Conference Location: Southfield, MI

Conference Dates: February 8, 2007
Conference Location: New York, NY; Bethesda, MD; Chicago, IL;

Sponsoring Group: The CBCE

Conference Web Page URL:

Topics Covered: Breast Cancer

Conference Objectives: Please see website for further information.

Who Should Attend: medical oncologists, surgical oncologists, radiation oncologists, nurses and pharmacists

Registration Information: Please call 877-263-6911 to register.

Conference Fees: Please see website for further information.

Continuing Education: Yes

SABCS: Combo Approaches Help Some Younger Breast CA Patients

Dec 12, 2014 - While tamoxifen plus ovarian suppression does not provide a significant benefit over tamoxifen alone among premenopausal women with hormone receptor-positive early breast cancer, the addition of ovarian suppression does benefit some of these women, and exemestane plus ovarian suppression further improves disease outcomes, according to new research. The findings were published online Dec. 11 in the New England Journal of Medicine to coincide with the annual San Antonio Breast Cancer Symposium, held from Dec. 9 to 13 in San Antonio.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More